{
     "PMID": "20043931",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20100719",
     "LR": "20131121",
     "IS": "1873-7064 (Electronic) 0028-3908 (Linking)",
     "VI": "58",
     "IP": "7",
     "DP": "2010 Jun",
     "TI": "Alpha1-adrenoceptors modulate citalopram-induced serotonin release.",
     "PG": "962-71",
     "LID": "10.1016/j.neuropharm.2009.12.018 [doi]",
     "AB": "Previous studies suggest that noradrenaline may regulate serotonergic (5-HT) neurotransmission at the serotonin cell body and noradrenaline nerve terminal. Using microdialysis coupled to HPLC, we investigated the effects of alpha1-adrenoceptor manipulation on extracellular serotonin levels - in the ventral hippocampus, prefrontal cortex, and raphe nuclei - in the presence or absence of the serotonin reuptake inhibitor (SSRI), citalopram. Extracellular 5-HT levels from prefrontal cortex, ventral hippocampus and raphe nuclei were markedly increased following citalopram administration (3.0 mg/kg s.c.). In the prefrontal cortex and ventral hippocampus, local blockade of the alpha1-adrenoceptor (3.0 microM prazosin infusion) significantly decreased this citalopram-induced increase in serotonin, while cirazoline (alpha1-adrenoceptor agonist) and reboxetine (noradrenaline reuptake inhibitor) further increased extracellular serotonin levels when administered systemically (0.02 mg/kg i.p. and 5.0 mg/kg s.c. respectively) or locally infused (10.0 microM and 1.0 microM respectively). Moreover, prazosin pre-infusion into terminal areas prevented the increase in citalopram-induced increase in serotonin levels with systemic cirazoline or reboxetine administration. Prazosin also decreased the citalopram-induced increase in serotonin levels in the raphe nuclei; however no enhancement of the SSRI response was observed with systemic or local administration of cirazoline or reboxetine, suggesting that alpha1-adrenoceptors may already be maximally activated under these conditions. These data provide strong evidence that after acute citalopram administration, the alpha1-adrenoceptor exerts a modulatory role on serotonin levels.",
     "CI": [
          "(c) 2009. Published by Elsevier Ltd."
     ],
     "FAU": [
          "Rea, Kieran",
          "Folgering, Joost",
          "Westerink, Ben H C",
          "Cremers, Thomas I F H"
     ],
     "AU": [
          "Rea K",
          "Folgering J",
          "Westerink BH",
          "Cremers TI"
     ],
     "AD": "Department of Pharmacology, National University of Ireland, Galway, Ireland.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20091231",
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (Adrenergic Uptake Inhibitors)",
          "0 (Adrenergic alpha-1 Receptor Agonists)",
          "0 (Adrenergic alpha-1 Receptor Antagonists)",
          "0 (Adrenergic alpha-Agonists)",
          "0 (Adrenergic alpha-Antagonists)",
          "0 (Imidazoles)",
          "0 (Morpholines)",
          "0 (Receptors, Adrenergic, alpha-1)",
          "0 (Serotonin Uptake Inhibitors)",
          "0DHU5B8D6V (Citalopram)",
          "333DO1RDJY (Serotonin)",
          "947S0YZ36I (reboxetine)",
          "QK318GVY3Y (cirazoline)",
          "XM03YJ541D (Prazosin)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic Uptake Inhibitors/pharmacology",
          "Adrenergic alpha-1 Receptor Agonists",
          "Adrenergic alpha-1 Receptor Antagonists",
          "Adrenergic alpha-Agonists/pharmacology",
          "Adrenergic alpha-Antagonists/pharmacology",
          "Animals",
          "Brain/*drug effects/*metabolism",
          "Citalopram/*pharmacology",
          "Extracellular Space/metabolism",
          "Hippocampus/drug effects/metabolism",
          "Imidazoles/pharmacology",
          "Male",
          "Morpholines/pharmacology",
          "Prazosin/pharmacology",
          "Prefrontal Cortex/drug effects/metabolism",
          "Raphe Nuclei/drug effects/metabolism",
          "Rats",
          "Rats, Wistar",
          "Receptors, Adrenergic, alpha-1/*metabolism",
          "Serotonin/*metabolism",
          "Serotonin Uptake Inhibitors/*pharmacology"
     ],
     "EDAT": "2010/01/02 06:00",
     "MHDA": "2010/07/20 06:00",
     "CRDT": [
          "2010/01/02 06:00"
     ],
     "PHST": [
          "2009/08/01 00:00 [received]",
          "2009/12/12 00:00 [revised]",
          "2009/12/17 00:00 [accepted]",
          "2010/01/02 06:00 [entrez]",
          "2010/01/02 06:00 [pubmed]",
          "2010/07/20 06:00 [medline]"
     ],
     "AID": [
          "S0028-3908(09)00396-7 [pii]",
          "10.1016/j.neuropharm.2009.12.018 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 2010 Jun;58(7):962-71. doi: 10.1016/j.neuropharm.2009.12.018. Epub 2009 Dec 31.",
     "term": "hippocampus"
}